RORα and RORβ, which modulate the transcription of Bmal1, were observed to be downregulated in gliomas, and this expression profile was prognostic in a cohort of glioma-diagnosed patients suggesting that its function is associated with tumor genesis and progression [213]. Here, BMAL1 is linked to central nervous system cancer.